Robust Antibody Levels in Both Diabetic and Non-Diabetic Individuals After BNT162b2 mRNA COVID-19 Vaccination

The emergence of effective vaccines for COVID-19 has been welcomed by the world with great optimism. Given their increased susceptibility to COVID-19, the question arises whether individuals with type-2 diabetes mellitus (T2DM) and other metabolic conditions can respond effectively to the mRNA-based...

Descripción completa

Detalles Bibliográficos
Autores principales: Ali, Hamad, Alterki, Abdulmohsen, Sindhu, Sardar, Alahmad, Barrak, Hammad, Maha, Al-Sabah, Salman, Alghounaim, Mohammad, Jamal, Mohammad H., Aldei, Ali, Mairza, Mohammad J., Husain, Maitham, Deverajan, Sriraman, Ahmad, Rasheed, Cherian, Preethi, Alkhairi, Irina, Alkandari, Abdullah, Abubaker, Jehad, Abu-Farha, Mohamed, Al-Mulla, Fahd
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8652288/
https://www.ncbi.nlm.nih.gov/pubmed/34899701
http://dx.doi.org/10.3389/fimmu.2021.752233

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8652288/
https://www.ncbi.nlm.nih.gov/pubmed/34899701
http://dx.doi.org/10.3389/fimmu.2021.752233

Ejemplares similares